Latest Breaking News On - Infiltrating lymphocytes - Page 7 : comparemela.com

Share this article SAN FRANCISCO, Feb. 18, 2021 /PRNewswire/ The global T-cell therapy market size is expected to reach USD 20.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 20.2% from 2021 to 2028. The milestone approvals of Kymriah and Yescarta along with the recent approval of Tecartus have bolstered the exponential revenue growth in the market . Key suggestions from the report: Research modality accounted for the largest revenue share with the growing pipeline of products entering clinical and pre-clinical phases The commercial base is expected to witness growth owing to the increasing regulatory approvals for commercial products across various countries as well as a rise in the number of medical centers implementing these therapies

United statesSouth africaSan franciscoAsia pacificSherry jamesCelgene corporationGilead sciences incView research incMerck kgaView researchPfizer incTherapeutics incMerck kgaaPharmaceuticals industryBluebird bio incGrand view research